Loading clinical trials...
Loading clinical trials...
The objective of the study is to assess the continued safety of the daily coadministration of ABT-335 in combination with rosuvastatin calcium, simvastatin or atorvastatin calcium.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Abbott
NCT06314919 · Primary Hypercholesterolemia, Mixed Dyslipidemia
NCT06932705 · Mixed Dyslipidemia
NCT05400317 · Mixed Dyslipidemia
NCT05621070 · Primary Hypercholesterolaemia and Mixed Dyslipidemia
NCT05399992 · Primary Hypercholesterolemia, Mixed Dyslipidemia
Medical Information Specialist
Abbott Park, Illinois
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions